| P50 | author | Philip Crosier | Q115705111 |
| | Kathryn Crosier | Q117259799 |
| | Stefan H Oehlers | Q44004389 |
| | Felix Ellett | Q47411769 |
| | Jonathan W. Astin | Q54335701 |
| | Graham J Lieschke | Q55149847 |
| | Kazuhide S. Okuda | Q55729560 |
| | Chris J Hall | Q62554929 |
| P2093 | author name string | Sultan Alasmari | |
| | June Pauline Misa | |
| P2860 | cites work | Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease | Q77887399 |
| | Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease | Q77904655 |
| | Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes | Q77947763 |
| | Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease | Q80119644 |
| | Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model | Q82251889 |
| | A chemical enterocolitis model in zebrafish larvae that is dependent on microbiota and responsive to pharmacological agents | Q83014456 |
| | Granulomas obstruct lymphatics in all layers of the intestine in Crohn's disease | Q87677838 |
| | Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema | Q22254202 |
| | VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development | Q24316025 |
| | Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase | Q24538742 |
| | Fiji: an open-source platform for biological-image analysis | Q27860912 |
| | Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins | Q28186603 |
| | A model for gene therapy of human hereditary lymphedema | Q28191040 |
| | Effective targeted gene 'knockdown' in zebrafish | Q29547445 |
| | The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish | Q30479482 |
| | Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos | Q30496444 |
| | mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. | Q30498615 |
| | Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish | Q30525639 |
| | Macrophages modulate adult zebrafish tail fin regeneration | Q30581353 |
| | lyve1 expression reveals novel lymphatic vessels and new mechanisms for lymphatic vessel development in zebrafish. | Q30581891 |
| | Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy | Q33354053 |
| | Live cell imaging of zebrafish leukocytes | Q33432098 |
| | Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. | Q33731734 |
| | Angiopoietin-2 in experimental colitis | Q33897226 |
| | Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature | Q34007272 |
| | VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease | Q34117538 |
| | ProxTom lymphatic vessel reporter mice reveal Prox1 expression in the adrenal medulla, megakaryocytes, and platelets | Q34152157 |
| | Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation | Q34161479 |
| | Metronidazole. A therapeutic review and update | Q34743506 |
| | Intestinal upregulation of melanin-concentrating hormone in TNBS-induced enterocolitis in adult zebrafish | Q35077963 |
| | Global analysis of hematopoietic and vascular endothelial gene expression by tissue specific microarray profiling in zebrafish | Q35606763 |
| | Downregulation of FoxC2 Increased Susceptibility to Experimental Colitis: Influence of Lymphatic Drainage Function? | Q35624894 |
| | Cardiac lymphatics are heterogeneous in origin and respond to injury. | Q35690246 |
| | Retinoic acid suppresses intestinal mucus production and exacerbates experimental enterocolitis | Q36051046 |
| | Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis | Q36241623 |
| | Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish | Q36253681 |
| | VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes | Q36384880 |
| | Increased lymphangiogenesis in joints of mice with inflammatory arthritis | Q36465469 |
| | Mechanisms of Disease: angiogenesis in inflammatory diseases | Q36984877 |
| | Blockade of VEGF receptor-3 aggravates inflammatory bowel disease and lymphatic vessel enlargement | Q37067138 |
| | Lymphatic vessel function in head and neck inflammation | Q37190282 |
| | Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm | Q37362124 |
| | Biological therapies for inflammatory bowel diseases | Q37403184 |
| | Dysregulated phosphatidylinositol signaling promotes endoplasmic-reticulum-stress-mediated intestinal mucosal injury and inflammation in zebrafish | Q37438514 |
| | Inflammatory bowel disease: pathogenesis | Q37454586 |
| | Inflammation-associated lymphangiogenesis: a double-edged sword? | Q37609665 |
| | Divergence of zebrafish and mouse lymphatic cell fate specification pathways | Q37618672 |
| | Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. | Q38081572 |
| | Inflammatory lymphangiogenesis: cellular mediators and functional implications | Q38180633 |
| | Vegfd can compensate for loss of Vegfc in zebrafish facial lymphatic sprouting | Q38306551 |
| | Vascular endothelial growth factor-C (VEGF-C) expression in normal human tissues. | Q38437135 |
| | Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice | Q39714957 |
| | KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. | Q40230481 |
| | VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment | Q40725945 |
| | The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development | Q40728953 |
| | Targeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli nitroreductase | Q41853648 |
| | Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages | Q41887679 |
| | M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis | Q42572043 |
| | In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study | Q43175881 |
| | Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries | Q43574335 |
| | Chemically induced intestinal damage models in zebrafish larvae. | Q44004332 |
| | Live imaging of lymphatic development in the zebrafish | Q44238801 |
| | In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. | Q44285254 |
| | The forgotten role of lymphangitis in Crohn's disease | Q44766457 |
| | Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease | Q44781743 |
| | Conditional targeted cell ablation in zebrafish: a new tool for regeneration studies | Q46051134 |
| | Development of the zebrafish lymphatic system requires VEGFC signaling | Q46076325 |
| | Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease. | Q46109702 |
| | Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. | Q46349781 |
| | Intestinal differentiation in zebrafish requires Cdx1b, a functional equivalent of mammalian Cdx2. | Q46357123 |
| | Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis | Q47073839 |
| | sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation | Q47074043 |
| | Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia | Q47726749 |
| | Nitroreductase-mediated cell ablation in transgenic zebrafish embryos | Q47982089 |
| | Cloning and characterization of vascular endothelial growth factor (VEGF) from zebrafish, Danio rerio | Q48038832 |
| | Analysis of soluble angiogenic factors in Crohn's disease: a preliminary study. | Q51729433 |
| | Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. | Q51734752 |
| | Zebrafish intestinal fatty acid binding protein (I-FABP) gene promoter drives gut-specific expression in stable transgenic fish. | Q52094094 |
| | DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular. | Q52619102 |
| | cKit Lineage Hemogenic Endothelium-Derived Cells Contribute to Mesenteric Lymphatic Vessels. | Q52958927 |
| | Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. | Q53640436 |
| | Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. | Q54360844 |
| | Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. | Q54449707 |
| | An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. | Q54727809 |
| | Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D. | Q54786757 |
| | Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40 | Q56994030 |
| | Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohnʼs disease patients | Q59509615 |
| | Identification and real-time imaging of a myc-expressing neutrophil population involved in inflammation and mycobacterial granuloma formation in zebrafish | Q60230208 |
| | Mesenteric lymphatic obstruction in Crohn's disease | Q71239047 |
| | VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation | Q73697862 |
| | Lymphatic vessels in the colonic mucosa in ulcerative colitis | Q73825023 |
| | Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease | Q74578513 |
| | Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease | Q74670283 |
| | Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease | Q75238154 |
| | Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease | Q75247873 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | lymphangiogenesis | Q6708231 |
| | Danio rerio | Q169444 |
| P304 | page(s) | 1270-1280 | |
| P577 | publication date | 2015-09-14 | |
| P1433 | published in | Biology Open | Q27724268 |
| P1476 | title | A zebrafish model of inflammatory lymphangiogenesis | |
| P478 | volume | 4 | |